NZ580746A - Cross-species-specific bispecific binders - Google Patents
Cross-species-specific bispecific bindersInfo
- Publication number
- NZ580746A NZ580746A NZ580746A NZ58074608A NZ580746A NZ 580746 A NZ580746 A NZ 580746A NZ 580746 A NZ580746 A NZ 580746A NZ 58074608 A NZ58074608 A NZ 58074608A NZ 580746 A NZ580746 A NZ 580746A
- Authority
- NZ
- New Zealand
- Prior art keywords
- seq
- depicted
- cdr
- human
- binding
- Prior art date
Links
Landscapes
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (8)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07006988 | 2007-04-03 | ||
| EP07006990 | 2007-04-03 | ||
| US91366807P | 2007-04-24 | 2007-04-24 | |
| EP07020646 | 2007-10-22 | ||
| EP07020640 | 2007-10-22 | ||
| EP07020641 | 2007-10-22 | ||
| EP08004741 | 2008-03-13 | ||
| PCT/EP2008/002663 WO2008119566A2 (en) | 2007-04-03 | 2008-04-03 | Cross-species-specific bispecific binders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ580746A true NZ580746A (en) | 2012-05-25 |
Family
ID=42582614
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ580746A NZ580746A (en) | 2007-04-03 | 2008-04-03 | Cross-species-specific bispecific binders |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JP2010524435A (show.php) |
| DK (1) | DK2155788T3 (show.php) |
| ES (1) | ES2390243T3 (show.php) |
| NZ (1) | NZ580746A (show.php) |
| PT (1) | PT2155788E (show.php) |
| RS (1) | RS52492B (show.php) |
| RU (1) | RU2535992C2 (show.php) |
| SI (1) | SI2155788T1 (show.php) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL2155788T3 (pl) * | 2007-04-03 | 2013-02-28 | Amgen Res Munich Gmbh | Swoiste międzygatunkowe bispecyficzne czynniki wiążące |
| HUE040467T2 (hu) * | 2007-04-03 | 2019-03-28 | Amgen Res Munich Gmbh | Keresztfaj-specifikus kötõdomén |
| US20130273055A1 (en) * | 2010-11-16 | 2013-10-17 | Eric Borges | Agents and methods for treating diseases that correlate with bcma expression |
| EP2710042A2 (en) * | 2011-05-16 | 2014-03-26 | Fabion Pharmaceuticals, Inc. | Multi-specific fab fusion proteins and methods of use |
| JP6141831B2 (ja) * | 2011-05-21 | 2017-06-07 | マクロジェニクス,インコーポレーテッド | ヒト及び非ヒトcd3に結合可能なcd3結合分子 |
| CN112390883A (zh) | 2013-12-17 | 2021-02-23 | 基因泰克公司 | 抗cd3抗体及使用方法 |
| EP3149041A1 (en) * | 2014-05-28 | 2017-04-05 | F. Hoffmann-La Roche AG | Antibodies binding to human and cynomolgus cd3 epsilon |
| CN107108738A (zh) * | 2014-07-25 | 2017-08-29 | 西托姆克斯治疗公司 | 抗cd3抗体、可活化抗cd3抗体、多特异性抗cd3抗体、多特异性可活化抗cd3抗体及其使用方法 |
| WO2016016415A1 (en) * | 2014-07-31 | 2016-02-04 | Amgen Research (Munich) Gmbh | Bispecific single chain antibody construct with enhanced tissue distribution |
| HK1250997A1 (zh) * | 2015-05-01 | 2019-01-18 | 基因泰克公司 | 掩蔽抗cd3抗体和使用方法 |
| CA3017776A1 (en) | 2016-03-15 | 2017-09-21 | Generon (Shanghai) Corporation Ltd. | Multispecific fab fusion proteins and use thereof |
| CA3042435A1 (en) | 2016-11-15 | 2018-05-24 | Genentech, Inc. | Dosing for treatment with anti-cd20/anti-cd3 bispecific antibodies |
| US10426424B2 (en) | 2017-11-21 | 2019-10-01 | General Electric Company | System and method for generating and performing imaging protocol simulations |
| CN118772287A (zh) | 2018-02-08 | 2024-10-15 | 豪夫迈·罗氏有限公司 | 双特异性抗原结合分子和使用方法 |
| JP7548587B2 (ja) | 2018-09-07 | 2024-09-10 | アイタブメッド (エイチケイ) リミテッド | 二重特異性抗原結合タンパク質及びその使用 |
| US20230067182A1 (en) * | 2019-11-29 | 2023-03-02 | Boe Technology Group Co., Ltd. | Data Processing Device and Method, and Computer Readable Storage Medium |
| AU2020403145B2 (en) | 2019-12-13 | 2025-06-26 | Genentech, Inc. | Anti-Ly6G6D antibodies and methods of use |
| JP2022087602A (ja) * | 2020-12-01 | 2022-06-13 | 株式会社バイオピーク | 組換え大腸菌による有用タンパク質の生産性を向上するための培養方法 |
| MX2023013363A (es) | 2021-05-14 | 2023-11-27 | Genentech Inc | Metodos para el tratamiento de un trastorno proliferativo cd20 positivo con mosunetuzumab y polatuzumab vedotina. |
| CN115932808B (zh) * | 2022-11-04 | 2025-05-27 | 四川九洲电器集团有限责任公司 | 一种基于多特征融合的被动声纳智能探测方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2179862C1 (ru) * | 2000-12-26 | 2002-02-27 | Общество с ограниченной ответственностью Научно-производственный центр "МедБиоСпектр" | Лекарственное средство для предотвращения отторжения трансплантата, моноклональное антитело к cd3-антигену т-лимфоцитов человека, гибридома и способ лечения больных, имеющих реакцию острого отторжения трансплантата после пересадки почки |
| JP5010281B2 (ja) * | 2003-05-31 | 2012-08-29 | マイクロメット アクツィエン ゲゼルシャフト | Epcamに対する二重特異性抗体を含む薬学的組成物 |
| US7235641B2 (en) * | 2003-12-22 | 2007-06-26 | Micromet Ag | Bispecific antibodies |
| SG155883A1 (en) * | 2004-06-03 | 2009-10-29 | Novimmune Sa | Anti-cd3 antibodies and methods of use thereof |
| BRPI0615745A2 (pt) * | 2005-09-12 | 2011-05-24 | Novimmune Sa | formulação de anticorpo anti-cd3 |
| EP1940881B1 (en) * | 2005-10-11 | 2016-11-30 | Amgen Research (Munich) GmbH | Compositions comprising cross-species-specific antibodies and uses thereof |
-
2008
- 2008-04-03 DK DK08735000.5T patent/DK2155788T3/da active
- 2008-04-03 NZ NZ580746A patent/NZ580746A/en unknown
- 2008-04-03 RS RS20120412A patent/RS52492B/sr unknown
- 2008-04-03 ES ES08735000T patent/ES2390243T3/es active Active
- 2008-04-03 SI SI200830762T patent/SI2155788T1/sl unknown
- 2008-04-03 RU RU2009136913/10A patent/RU2535992C2/ru active
- 2008-04-03 JP JP2010501433A patent/JP2010524435A/ja not_active Revoked
- 2008-04-03 PT PT08735000T patent/PT2155788E/pt unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SI2155788T1 (sl) | 2012-11-30 |
| ES2390243T3 (es) | 2012-11-07 |
| RS52492B (sr) | 2013-02-28 |
| PT2155788E (pt) | 2012-09-25 |
| DK2155788T3 (da) | 2012-10-08 |
| JP2010524435A (ja) | 2010-07-22 |
| RU2009136913A (ru) | 2011-06-20 |
| RU2535992C2 (ru) | 2014-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20200095319A1 (en) | Cross-species-specific bispecific binders | |
| US11987633B2 (en) | Cross-species-specific single domain bispecific single chain antibody | |
| EP2520590B1 (en) | Cross-species-specific binding domain | |
| CA2683370C (en) | Cross-species-specific binding domain | |
| NZ580746A (en) | Cross-species-specific bispecific binders | |
| US20230357444A1 (en) | Cross-species-specific binding domain | |
| HK40072623A (en) | Cross-species-specific binding domain | |
| HK1141299B (en) | Cross-species-specific bispecific binders | |
| HK40006433A (en) | Cross-species-specific binding domain | |
| HK1178542B (en) | Cross-species-specific binding domain | |
| HK1178542A (en) | Cross-species-specific binding domain | |
| HK1141300B (en) | Cross-species-specific cd3-epsilon binding domain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) | ||
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2016 BY CPA GLOBAL Effective date: 20150306 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2017 BY CPA GLOBAL Effective date: 20160304 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2018 BY CPA GLOBAL Effective date: 20170303 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2019 BY CPA GLOBAL Effective date: 20180301 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2020 BY CPA GLOBAL Effective date: 20190307 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2021 BY CPA GLOBAL Effective date: 20200306 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2022 BY CPA GLOBAL Effective date: 20210305 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2023 BY ANAQUA SERVICES Effective date: 20220323 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2024 BY ANAQUA SERVICES Effective date: 20230321 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2025 BY ANAQUA SERVICES Effective date: 20240320 |
|
| RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 1 YEAR UNTIL 03 APR 2026 BY ANAQUA SERVICES Effective date: 20250319 |